PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|May 6, 2020
- Pharmaceutical Technology's In the Lab eNewsletter-05-06-2020
- Volume 15
- Issue 5
Fluid Air Launches the PolarDry Electrostatic Spray Dryer, Model 0.1
The spray dryer can be disassembled for autoclave sterilization and works to produce small-scale samples with minimum product loss.
Advertisement
Fluid Air introduced the PolarDry Electrostatic Spray Dryer, Model 0.1, its newest spray dry and microencapsulation product for feasibility testing.
According to a company press release, the spray dryer can be disassembled for autoclave sterilization and works to produce small-scale samples with minimum product loss. Additionally, the small size of the spray dryer allows for it to fit inside most lab fume or containment hoods, where noxious solvents, potent APIs, and oxygen sensitive materials are tested, making the exploration of new products more efficient and cost-effective before full-scale testing.
Articles in this issue
over 6 years ago
Centogene to Open New Lab for COVID-19 Testingover 6 years ago
Miele Wins iF Design Awards for Laboratory Glasswashersover 6 years ago
Solentim, ATUM Parnter on Cell Line Developmentover 6 years ago
New Biobanking LIMS Accelerator for Managing COVID-19 TestingAdvertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement